(Q37944911)

25 August 2017

title

Glucocorticoid sensitivity in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

25 August 2017

main subject

0 references

0 references

2

1 reference

25 August 2017

Marianne Sidoroff

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

13 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

44

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

578-587

1 reference

Cortisone in ulcerative colitis; final report on a therapeutic trial.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Further experience in the treatment of severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Review article: the limitations of corticosteroid therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

The pattern and outcome of acute severe colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Clinical pharmacokinetics of prednisone and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Pharmacokinetic considerations in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

A unified nomenclature system for the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

The glucocorticoid receptor gene is in 5q–q32

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Alpha and beta glucocorticoid receptors: relevance in airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptor mRNA in patients with ulcerative colitis: a study of responders and nonresponders to glucocorticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Transactivation assay for determination of glucocorticoid bioactivity in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

New means to monitor the effect of glucocorticoid therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Pharmacogenomics in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Predicting outcome in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Glucocorticoid resistance in inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

The human glucocorticoid receptor: molecular basis of biologic function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

Polymorphisms of Tumor Necrosis Factor-α but Not MDR1 Influence Response to Medical Therapy in Pediatric-Onset Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.590521

10.3109/07853890.2011.590521

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference